Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Major AI breakthrough by Optalysys demonstrating how its Patented Optical Processing Technology performs Deep Learning at the Speed of Light

Optalysys Ltd.
Posted on: 19 Mar 18

YORKSHIRE, United Kingdom, March 19, 2018 (GLOBE NEWSWIRE) --  Optalysys Ltd . (@ Optalysys ), an innovative technology company commercialising light-speed optical coprocessors for AI/Deep Learning today announced they had successfully built the world's first implementation of a Convolutional Neural Network using their Optical Processing Technology.

Convolutional Neural Networks, or CNNs, is a rapidly expanding area of Machine Learning Image Recognition and Analysis, used in  pivotal applications such as Autonomous Vehicles, Weather Forecasting and Medical Image Analysis.  These models are computationally extremely intensive, particularly for complex models, where there can be many convolutional "layers" to process. 

The use of CNNs has advanced in recent years largely through the advancement of graphics processors. However, even though these offer considerable advantages over conventional processors, they are limited by the breakdown of Moore's Law, and the high energy costs which can run into several millions of dollars for top-end supercomputers.

Optalysys's optical processing technology brings major adavantages by using a fundamentally different approach with energy efficient laser light rather than silicon as the processing medium.  This  delivers speed improvements of several orders of magnitude over conventional computing at a fraction of the energy consumption.

"This is a hugely significant leap forward for the field of AI and clearly demonstrates the global potential for our Enabling Technology." said Dr. Nick New, founder and CEO of Optalysys. "Optalysys has for the first time ever, applied optical processing to the highly complex and computationally demanding area of CNNs with initial accuracy rates of over 70%.   Through our uniquely scalable and highly efficient optical approach, we are developing models that will offer whole new levels of capability, not only cloud-based but also opening up the extraordinary potential of CNNs to mobile systems."  

The demonstration successfully shows the Optalysys Optical Processing Technology processing a CNN, using the popular MNIST data set of hand-drawn numerals, which contains 60,000 training characters and 10,000 testing characters.

About OPTALYSYS
Optalysys is developing Optical Computing Platforms, which enable a quantum leap into new levels of processing capability. Delivered at a fraction of the cost with a vastly reduced energy consumption compared with conventional computers. Its first coprocessor is based on an established diffractive optical approach that uses the photons of low-power laser light instead of conventional electricity and its elctrons. This inherently parallel technology is highly scalable and is the new paradigm of computing.

Press Contacts:
Emma Blaylock
Optalysys Ltd
Emma.blaylock@optalysys.com
+44 1977 551615



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Optalysys Ltd. via GlobeNewswire
HUG#2177029
GlobeNewswire
globenewswire.com

Last updated on: 20/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.